文献速递生殖医学

自体干细胞卵巢移植提高低反应患者生育潜能

Autologous stem cell ovarian transplantation to increase reproductive potential in patients who are poor responders.
PubMed 文献 · Fertil Steril · 2018-06-28

该前瞻性观察性先导研究纳入17例预后极差的低反应患者,行骨髓来源干细胞卵巢输注(ASCOT),以窦卵泡计数(AFC)和抗苗勒管激素(AMH)评估卵巢储备及IVF结局。ASCOT后2周AFC显著改善,81.3%患者卵巢功能改善,获5例妊娠,但胚胎整倍体率低(16.1%)。

要点

  • ASCOT后2周AFC显著改善,81.3%患者卵巢功能改善。
  • 控制性卵巢刺激后获卵数增加,但胚胎整倍体率低(16.1%)。
  • 共获5例妊娠:2例胚胎移植后,3例自然受孕。

核心结论

  • ASCOT可能优化了现有卵泡的动员和生长,可能与血浆分离产物中的成纤维细胞生长因子-2和血小板反应蛋白-1有关。
  • ASCOT改善了低反应患者的卵泡和卵母细胞数量,使先前仅限于卵母细胞捐赠的妇女得以妊娠。

研究设计与样本

  • 前瞻性观察性先导研究,在大学医院开展,纳入17例低反应患者,干预为骨髓来源干细胞卵巢输注,临床试验注册号NCT02240342。

主要发现

  • ASCOT后2周AFC显著改善。
  • 以AFC增加3个或以上卵泡和/或AMH连续两次升高为成功标准,81.3%的妇女卵巢功能改善。
  • 这些积极效应与成纤维细胞生长因子-2和血小板反应蛋白的存在相关。
  • 控制性卵巢刺激期间,ASCOT增加了可刺激窦卵泡和卵母细胞数量,但胚胎整倍体率低(16.1%)。
  • 共获5例妊娠:2例胚胎移植后,3例自然受孕。

关键数值与推荐

  • 成功标准为AFC增加3个或以上卵泡和/或AMH连续两次升高,81.3%的妇女达到卵巢功能改善。
  • 胚胎整倍体率为16.1%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate effects of autologous stem cell ovarian transplant (ASCOT) on ovarian reserve and IVF outcomes of women who are poor responders with very poor prognosis. DESIGN: Prospective observational pilot study. SETTING: University hospital. PATIENT(S): Seventeen women who are poor responders. INTERVENTION(S): Ovarian infusion of bone marrow-derived stem cells. MAIN OUTCOME MEASURE(S): Serum antimüllerian hormone levels and antral follicular count (AFC), punctured follicles, and oocytes retrieved after stimulation (controlled ovarian stimulation) were measred. Apheresis was analyzed for growth factor concentrations. RESULT(S): The ASCOT resulted in a significant improvement in AFC 2 weeks after treatment. With an increase in AFC of three or more follicles and/or two consecutive increases in antimüllerian hormone levels as success criteria, ovarian function improved in 81.3% of women. These positive effects were associated with the presence of fibroblast growth factor-2 and thrombospondin. During controlled ovarian stimulation, ASCOT increased the number of stimulable antral follicles and oocytes, but the embryo euploidy rate was low (16.1%). Five pregnancies were achieved: two after ET, three by natural conception. CONCLUSION(S): Our results suggest that ASCOT optimized the mobilization and growth of existing follicles, possibly related to fibroblast growth factor-2 and thrombospondin-1 within apheresis. The ASCOT improved follicle and oocyte quantity enabling pregnancy in women who are poor responders previously limited to oocyte donation. CLINICAL TRIAL REGISTRATION NUMBER: NCT02240342.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Herraiz S, Romeu M, Buigues A, et al. Autologous stem cell ovarian transplantation to increase reproductive potential in patients who are poor responders. Fertil Steril. 2018. PMID: 29960701. doi:10.1016/j.fertnstert.2018.04.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。